Filter
1995
Filtered Results: 1995
Text search:
metaanalysis
Featured
Recommendations
196
New Publications
267
Language
Document type
No document type
946
Guidelines
427
Studies & Reports
418
Manuals
68
Fact sheets
64
Strategic & Response Plan
38
Training Material
16
Resource Platforms
9
Situation Updates
6
Infographics
2
Brochures
1
Countries / Regions
Global
92
India
60
Russia
51
Western and Central Europe
42
Brazil
37
Latin America and the Carribbean
34
Germany
32
Africa
29
South Africa
29
Kenya
25
Eastern Europe
23
Ukraine
20
Malawi
17
Middle East and North Africa
17
Ethiopia
17
Mozambique
16
Tanzania
13
Uganda
13
Asia
12
Indonesia
12
Nepal
11
Syria
11
Nigeria
11
Senegal
11
Argentina
11
Zambia
11
Colombia
10
Philippines
10
Eastern Europe and Central Asia
9
Yemen
9
Ghana
8
Sierra Leone
8
Rwanda
8
Burkina Faso
8
Congo, Democratic Republic of
8
West and Central Africa
8
South–East Asia Region
8
Bangladesh
8
Angola
8
Chile
7
Cameroon
7
Peru
7
Zimbabwe
7
Guinea-Bissau
6
East and Southern Africa
6
Myanmar / Burma
6
USA
5
Cambodia
5
Paraguay
5
Spain
5
Namibia
5
Botswana
5
South Sudan
5
Thailand
4
Lesotho
4
United Kingdom
4
Vietnam
4
Mali
4
Liberia
4
Ecuador
4
Benin
3
Estonia
3
Kyrgyzstan
3
Haiti
3
Jordan
3
Portugal
3
Eswatini/ Swaziland
3
Tajikistan
2
Mexico
2
Turkey
2
China
2
Canada
2
Niger
2
Afghanistan
2
Burundi
2
Guinea
2
Venezuela
2
France
2
Southern Africa
2
Sri Lanka
2
Sudan
2
Honduras
2
Pakistan
2
North Macedonia
1
Switzerland
1
Timor Leste/ East Timor
1
Kazakhstan
1
Iran
1
Singapore
1
Laos
1
Qatar
1
Armenia
1
Western Pacific Region
1
North America
1
Uruguay
1
Belgium
1
Belarus
1
Israel
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Lebanon
1
Moldova
1
Egypt
1
Romania
1
Palestine
1
Georgia
1
Chad
1
Iraq
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
459
Clinical Guidelines
231
Women & Child Health
126
Public Health
119
Key Resources
42
Capacity Building
13
Pharmacy & Technologies
13
Toolboxes
Mental Health
345
COVID-19
315
HIV
251
TB
186
NCDs
103
Planetary Health
72
AMR
51
NTDs
45
Caregiver
43
Disability
42
Refugee
33
Rapid Response
19
Pharmacy
18
Global Health Education
16
Ebola
13
Conflict
11
Cholera
8
Zika
6
Polio
5
Specific Hazards
4
Health Financing Toolbox
4
Natural Hazards
3
Social Ethics
3
Neurology and COVID-19. Scientific report 29 September 2021
scientific brief, 2 March 2022
Mortality statistics are fundamental to public health decision making. Mortality varies by time and location, and its measurement is affected by well known biases that have been exacerbated during the COVID-19 pandemic. This paper aims to estimate excess mortality from ...
WHO's Health in the Green Economy sector briefings examine the health impacts of climate change mitigation strategies considered by the Intergovernmental Panel on Climate Change in their Fourth Assessment Report.
Front. Public Health, 30 April 2021 | https://doi.org/10.3389/fpubh.2021.628744
La presente guía tiene además como objetivo, ser un respaldo y no una camisa de fuerza para los médicos, pues pretendemos con ella proveer evidencia sólida respecto a los riesgos, beneficios o consecuencias que puede generar la toma de una decisión en pacientes con tuberculosis. Como lo propone...
Ethnic disparities in COVID-19 persist, with increased rates of infection, severe disease, and death among people from minority ethnic groups. COVID-19 vaccination rates also remain lowest in these communities compared with white people in the UK. Among people older than 18 years, the proportion who...
Preventing tuberculosis infection from progressing to tuberculosis disease is a crucial component of the goal to eliminate tuberculosis. When deciding on the use of tuberculosis preventive therapy among household contacts, policy makers regularly ask questions, such as whether tuberculosis preventiv...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
Guía Clínica – Diabetes Mellitus tipo 1
Lancet Planet Health 2022;6: e760–68
The emergence of COVID-19 has drawn the attention of health researchers sharply back to the role that food systems can play in generating human disease burden. But emerging pandemic threats are just one dimension of the complex relationship between agriculture...
Policy Brief. More languages available here https://apps.who.int/iris/handle/10665/179517
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...
Snakebite envenoming affects millions of people worldwide annually and is a significant source of mortality. Preventing and treating the problem is complex and requires collaboration among the fields of public health, medicine, ecology, and laboratory science. After being removed from the category A...
In 2014, an estimated 40 million women of reproductive age were infected with Schistosoma haematobium, S. japonicum and/or S. mansoni. In both 2003 and 2006, the World Health Organization (WHO) recommended that all schistosome-infected pregnant and breastfeeding women be offered treatment, with praz...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
Diabetes mellitus (DM) is a global epidemic with significant morbidity. Diabetic
retinopathy (DR) is the specific microvascular complication of DM and affects 1 in 3 persons with DM. DR remains a leading cause of vision loss in working adult populations. Patients with severe levels of DR are report...
Prevention of stroke and transient ischemic attack includes both conventional approaches to vascular risk factor management (blood pressure lowering, cholesterol reduction with statins, smoking cessation and antiplatelet therapy)
and more specific interventions, such as carotid revascularization or...
Cardiovascular diseases (CVDs) have collectively remained the leading causes of death worldwide and substantially contribute to loss of health and excess health system costs. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study has tracked trends in death and disability since 1990 a...
Developed as part of the UN Women–WHO Global Joint Programme on Violence Against Women Data, this briefing note focuses on the measurement of violence against women with disability and is one in a series of methodological briefing notes for strengthening the measurement and data collection of viol...
